These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19102682)

  • 1. Enhancing the divergent activities of betulinic acid via neoglycosylation.
    Goff RD; Thorson JS
    Org Lett; 2009 Jan; 11(2):461-4. PubMed ID: 19102682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of natural and modified betulinic, ursolic and echinocystic acid derivatives as potential antitumor and anti-HIV agents.
    Baglin I; Mitaine-Offer AC; Nour M; Tan K; Cavé C; Lacaille-Dubois MA
    Mini Rev Med Chem; 2003 Sep; 3(6):525-39. PubMed ID: 12871156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in the study of structural modifications and biological activities of betulinic acids].
    Lan P; Zhang DM; Chen WM; Ye WC
    Yao Xue Xue Bao; 2010 Nov; 45(11):1339-45. PubMed ID: 21361032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Betulinic Acid and its Derivatives as Potential Antitumor Agents.
    Zhang DM; Xu HG; Wang L; Li YJ; Sun PH; Wu XM; Wang GJ; Chen WM; Ye WC
    Med Res Rev; 2015 Nov; 35(6):1127-55. PubMed ID: 26032847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and Anti-HIV Activity of Betulinic Acid Analogues.
    Huang QX; Chen HF; Luo XR; Zhang YX; Yao X; Zheng X
    Curr Med Sci; 2018 Jun; 38(3):387-397. PubMed ID: 30074203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection.
    Cichewicz RH; Kouzi SA
    Med Res Rev; 2004 Jan; 24(1):90-114. PubMed ID: 14595673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betulinic acid and its derivatives: a review on their biological properties.
    Yogeeswari P; Sriram D
    Curr Med Chem; 2005; 12(6):657-66. PubMed ID: 15790304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors.
    Dang Z; Lai W; Qian K; Ho P; Lee KH; Chen CH; Huang L
    J Med Chem; 2009 Dec; 52(23):7887-91. PubMed ID: 19526990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives.
    Huang L; Ho P; Lee KH; Chen CH
    Bioorg Med Chem; 2006 Apr; 14(7):2279-89. PubMed ID: 16314103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and studies of anticancer properties of lupane-type triterpenoid derivatives containing a cisplatin fragment.
    Emmerich D; Vanchanagiri K; Baratto LC; Schmidt H; Paschke R
    Eur J Med Chem; 2014 Mar; 75():460-6. PubMed ID: 24561674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification.
    Ding W; Sun M; Luo S; Xu T; Cao Y; Yan X; Wang Y
    Molecules; 2013 Aug; 18(9):10228-41. PubMed ID: 23973995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorinated betulinic acid derivatives and evaluation of their anti-HIV activity.
    Li J; Goto M; Yang X; Morris-Natschke SL; Huang L; Chen CH; Lee KH
    Bioorg Med Chem Lett; 2016 Jan; 26(1):68-71. PubMed ID: 26598461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and anti-tumor activity of novel betulinic acid derivatives.
    Liu JH; Tang J; Zhu ZF; Chen L
    J Asian Nat Prod Res; 2014 Jan; 16(1):34-42. PubMed ID: 24350921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and cytotoxicity of triterpenoids derived from betulin and betulinic acid via click chemistry.
    Shi W; Tang N; Yan WD
    J Asian Nat Prod Res; 2015; 17(2):159-69. PubMed ID: 25379995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Synthesis of NO-releasing Betulinic Acid Derivatives as Potential Anticancer Agents.
    Liu J; Zhu Z; Tang J; Lin Q; Chen L; Sun J
    Anticancer Agents Med Chem; 2017; 17(2):241-249. PubMed ID: 27671295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor activities of triterpenes from Syzygium kusukusense.
    Bai LY; Lin WY; Chiu CF; Weng JR
    Nat Prod Commun; 2014 Nov; 9(11):1557-8. PubMed ID: 25532279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents.
    Cui HW; He Y; Wang J; Gao W; Liu T; Qin M; Wang X; Gao C; Wang Y; Liu MY; Yi Z; Qiu WW
    Eur J Med Chem; 2015 May; 95():240-8. PubMed ID: 25817774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological activity and pharmacological prospects of lupane terpenoids: I. Natural lupane derivatives].
    Tolstikova TG; Sorokina IV; Tolstikov GA; Tolstikov AG; Flekhter OB
    Bioorg Khim; 2006; 32(1):42-55. PubMed ID: 16523720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer activity of 3-O-acylated betulinic acid derivatives obtained by enzymatic synthesis.
    Ahmad FB; Ghaffari Moghaddam M; Basri M; Abdul Rahman MB
    Biosci Biotechnol Biochem; 2010; 74(5):1025-9. PubMed ID: 20460723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-HIV activity of 3-alkylamido-3-deoxy-betulinic acid derivatives.
    Kashiwada Y; Chiyo J; Ikeshiro Y; Nagao T; Okabe H; Cosentino LM; Fowke K; Morris-Natschke SL; Lee KH
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1387-90. PubMed ID: 10993248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.